Skip to content

13F-HR filed by FCPM III SERVICES B.V.

FCPM III SERVICES B.V. filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 10 holding rows worth $722,206,839.

Accession
0001193125-26-225423
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 14 entries on the cover page, a total value of $722,206,839 stated on the cover page (in dollars after the unit check, H1), rows summing to $722,206,839 with VALUE read as dollars as filed, 13F file number 028-24008. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerForbion Growth Management B.V. 028-24009
  • included managerForbion IV Management B.V. 028-24010
  • included managerForbion Growth Management III B.V. 028-26443

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK9,198,900$294,456,789dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock4,644,386$84,202,718dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK4,117,354$73,453,595dollars as filed
ENGENE HOLDINGS INC29286M105COM9,632,561$65,597,740dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK3,226,400$65,592,712dollars as filed
DAMORA THERAPEUTICS INC36322Q206COMMON STOCK2,441,000$63,221,900dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK1,677,852$30,822,141dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK2,808,368$21,484,015dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS3,468,430$16,093,515dollars as filed
ENGENE HOLDINGS INC29286M113W EXP 10/31/20282,878,148$7,281,714dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-225423this filing2026-05-15acceptance time not in the bulk data set